Its hard to anticipate how it will affect each person
Mechanisms and functions of inflammasomes
Kopetz S , Morris VK, Parikh N, Overman MJ, Jiang ZQ, Maru D, Elvin P, Gallick G
Taff HT, Nett JE, Zarnowski R, Ross KM, Sanchez H, Cain MT, Hamaker J, Mitchell AP, Andes DR (2012) A Candida biofilm-induced pathway for matrix glucan delivery: implications for drug resistance
Third, the study population focused on European ancestry, which might limit the generalization of our findings to other populations
But what we are seeing is that GLP-1 coverage is getting more accessible for specific conditions sleep apnea, diabetes, extremely high BMI or a combination of these things but for other conditions, coverage is probably going to get more restrictive